IDH2 and acute myeloid leukemia: We analyzed a total of 363 patients with AML, whereby 298 (82.1%) had no IDH1/2 mutation (IDH1/2wildtypeAML), and 65 (17.9%) exhibited either an IDH1 or an IDH2 mutation.